<img class="aligncenter size-large wp-image-1380944" src="https://i2.wp.com/www.vanguardngr.com/wp-content/uploads/2020/04/WHO-1.jpg?resize=640%2C671&#038;ssl=1" alt="Safety paramount in vaccine trials, suspensions 'not unusual' — WHO" width="640" height="671" srcset="https://i2.wp.com/www.vanguardngr.com/wp-content/uploads/2020/04/WHO-1.jpg?resize=976%2C1024&amp;ssl=1 976w, https://i2.wp.com/www.vanguardngr.com/wp-content/uploads/2020/04/WHO-1.jpg?resize=286%2C300&amp;ssl=1 286w, https://i2.wp.com/www.vanguardngr.com/wp-content/uploads/2020/04/WHO-1.jpg?resize=768%2C805&amp;ssl=1 768w, https://i2.wp.com/www.vanguardngr.com/wp-content/uploads/2020/04/WHO-1.jpg?resize=55%2C58&amp;ssl=1 55w, https://i2.wp.com/www.vanguardngr.com/wp-content/uploads/2020/04/WHO-1.jpg?resize=185%2C194&amp;ssl=1 185w, https://i2.wp.com/www.vanguardngr.com/wp-content/uploads/2020/04/WHO-1.jpg?resize=124%2C130&amp;ssl=1 124w, https://i2.wp.com/www.vanguardngr.com/wp-content/uploads/2020/04/WHO-1.jpg?w=1192&amp;ssl=1 1192w" sizes="(max-width: 640px) 100vw, 640px" data-recalc-dims="1" /> Safety is paramount in vaccine clinical trials and temporary suspensions are not unusual to evaluate any unexplained illness in a participant, the World Health Organization (WHO) said on Thursday regarding the pause in an AstraZeneca COVID-19 trial. AstraZeneca has suspended global trials of its experimental coronavirus vaccine after an unexplained illness in a participant, knocking the British drugmaker’s shares on Wednesday as prospects for an early rollout dimmed. “We are pleased to see vaccine developers assuring the scientific integrity of the trials and abiding by the standard guidelines and rules for the development of vaccines,” the WHO said by email in response to a Reuters query. The WHO recommended “strict adherence to established testing protocols in all vaccine trials to ensure the safety of volunteers and the eventual safety and efficacy of vaccines”, it added. Reuters Vanguard By Chioma Obinna A team of scientists at Oxford University’s Jenner Institute and Oxford Vaccine Group has taken the next step towards the discovery of a safe, effective, and accessible vaccine against Coronavirus. The results of Phase I/II trial published on the 20th of July 2020 in the scientific journal,… July 22, 2020 In "Health" President Vladimir Putin said on Tuesday that Russia had become the first country in the world to grant regulatory approval to a COVID-19 vaccine after less than two months of human testing, a move hailed by Moscow as evidence of its scientific prowess. The development paves the way for the… August 11, 2020 In "Coronavirus Updates" Clinical trials on one of the most advanced experimental Covid-19 vaccines, which is being developed by pharmaceutical company AstraZeneca and Oxford University, were "paused" Tuesday after a volunteer developed an unexplained illness. With billions of people around the world still suffering with the fallout of the pandemic and the global… September 9, 2020 In "Coronavirus Updates"